mitomycin has been researched along with tamoxifen in 57 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 17 (29.82) | 18.7374 |
1990's | 25 (43.86) | 18.2507 |
2000's | 6 (10.53) | 29.6817 |
2010's | 8 (14.04) | 24.3611 |
2020's | 1 (1.75) | 2.80 |
Authors | Studies |
---|---|
Hansch, C; Khwaja, TA; Selassie, CD | 1 |
Bacsó, Z; Cianfriglia, M; Fenyvesi, F; Goda, K; Kappelmayer, J; Lustyik, G; Nagy, H; Szabó, G; Szilasi, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Ali, MM; El Diwani, HI; Galal, SA; Kerwin, SM; Li, J; Omar, MA; Ramadan, RA; Shaker, YM; Tokuda, H | 1 |
Bhattacharya, AK; Iram, S; Khan, MS; Polanki, IK; Rana, KC; Raut, DS | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Miura, T; Murata, M; Seki, M; Shinohara, K; Takagi, S; Tezuka, T | 1 |
Akagi, M; Dohi, K; Hamada, Y; Hattori, T; Inokuchi, K; Monden, Y; Nomura, Y; Orita, K; Sugimachi, K; Toi, M | 1 |
Aiba, K; Hirano, A; Horikoshi, N; Inoue, K; Itami, S; Matsumura, T; Matsuoka, A; Mizunuma, N; Mukaiyama, T; Ogawa, M | 1 |
Asakura, T; Fukuda, M; Imaki, S; Kanasugi, K; Komoriyama, H; Morikubo, M; Okamura, R; Tsukikawa, S; Watanabe, H; Yamaguchi, S | 1 |
Friedman, S; Mouriesse, H; Rouëssé, J; Sarrazin, D; Spielmann, M | 1 |
Inaji, H; Iwanaga, T; Koyama, H; Noguchi, S; Wada, A; Yamamoto, H | 1 |
A'Hern, RP; Fisher, C; Harmer, CL; Mansi, JL; McKinna, JA; Sinnett, HD; Smith, IE; Trott, PA; Walsh, G | 1 |
Kitaoka, H; Ohkura, H | 1 |
Hirai, T; Iino, Y; Ishida, T; Izuo, M; Kawai, T; Ogawa, T; Suzuki, H; Yokoe, T | 1 |
Abe, K; Adachi, I; Suzuki, M; Tsuchihashi, T; Yamaguchi, K | 1 |
Kitaoka, H | 3 |
Koh, J | 1 |
Hisamatsu, K; Nomura, Y; Shinozuka, K; Tashiro, H | 1 |
Abe, R; Abo, S; Koie, H; Mori, S; Motoki, R; Ono, K; Saito, K; Sato, T; Tsuchiya, A; Tsukamoto, M | 1 |
Takahashi, T | 1 |
Asselain, B; Bretaudeau, B; Garcia-Giralt, E; Jouve, M; Magdelenat, H; Palangie, T; Pouillart, P | 1 |
Nomura, Y | 1 |
Abe, O; Asanuma, F; Enomoto, K; Ishibiki, K; Koh, J; Kubota, T; Kubouchi, K | 1 |
Abe, O; Asanuma, F; Enomoto, K; Hanatani, Y; Ishibiki, K; Koh, J; Kubota, T; Kubouchi, K; Kurihara, H | 1 |
Chang, YC; Crowley, J; Falkson, G; Tormey, DC | 1 |
Takeuchi, T | 1 |
Casey, S; O'Brien, ME; Powles, TJ; Treleaven, J | 1 |
Ikeda, T | 1 |
Abe, R; Abo, S; Kikuchi, K; Koie, H; Mori, S; Ono, K; Saito, K; Sato, T; Tsuchiya, A; Tsukamoto, M | 1 |
Kajimura, N; Miyazaki, N; Ohkura, H; Okazaki, N | 1 |
Kobayashi, S; Miyazaki, I; Mizumoto, R; Nimura, Y; Noguchi, M; Saji, S; Takagi, H; Takeuchi, S; Tsuda, H; Yoshida, M | 1 |
Ashley, SE; Luckit, J; Montes, A; O'Brien, ME; Powles, TJ; Treleaven, J | 1 |
King, DM; Mansi, JL; Moskovic, EC; Murch, CR; Smith, IE | 1 |
Guy, RL; Husband, JE; Knee, G; MacVicar, AD; Powles, TJ; Sloane, JP; Vinnicombe, SJ | 1 |
Dohi, K; Monden, Y; Morimoto, T; Nomura, Y; Ogawa, M; Ogawa, N; Orita, K; Sugimachi, K; Toge, T | 1 |
Matsumine, T; Matsumoto, J; Minami, T; Takami, M; Takanishi, K | 1 |
Ellis, PA; Luckitt, J; Smith, IE; Treleaven, J | 1 |
Inaji, H; Koyama, H; Motomura, K; Noguchi, S | 1 |
Asanuma, F; Miyagawa, T; Toyoda, H; Uesato, K; Yamada, Y | 1 |
Nomura, Y; Shirouzu, M; Takayama, T | 1 |
Allred, DC; Ashley, SE; Dowsett, M; Fernando, IN; Gregory, RK; Makris, A; Ormerod, MG; Osborne, CK; Powles, TJ; Titley, JC; Trott, PA | 1 |
Murakami, S; Nomura, Y; Takenaka, Y; Tsutsui, S | 2 |
Ashley, S; Kuan, A; Kulkarni, S; Mehta, J; Mitchell, P; Powles, R; Powles, T; Saso, R; Swansbury, GJ; Treleaven, J | 1 |
Aho, H; Arola, O; Asola, M; Kauppila, M; Nikkanen, V; Voipio-Pulkki, LM | 1 |
Akasaka, Y; Hata, Y; Nakanishi, Y; Ogita, M; Sasaki, F; Sawada, Y; Takahashi, H; Uchino, J; Yoshimoto, M | 1 |
Fischer, WH; Keiwan, A; Schmitt, E; Stopper, H | 1 |
Chen, JW; Huo, YC; Pan, DY; Qiao, JG; Shi, HA; Zhou, YK | 1 |
Hiraoka, M; Imagunbai, T; Inoue, T; Mitsumori, M; Negoro, Y; Sai, H; Sasaki, S; Sasaki, Y; Shikama, N; Takegawa, H; Teshima, T; Yamauchi, C | 1 |
He, YP; Liu, ZH; Ma, YL; Qin, H; Zhang, P; Zhou, YK | 1 |
Batista da Costa, J; Black, PC; Mannas, M; Nykopp, TK | 1 |
Chapple, CR; Chatters, R; Downey, AP; Harding, CK; Hind, D; Osman, NI; Pang, KH; Watkin, N | 1 |
5 review(s) available for mitomycin and tamoxifen
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
["State of the art" of adjuvant chemo-endocrine therapy for breast cancer in Japan].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials as Topic; Doxorubicin; Female; Humans; Japan; Mitomycin; Tamoxifen; Tegafur | 1994 |
[Benefits of adjuvant chemotherapy for breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Drug Combinations; Female; Fluorouracil; Humans; Lymphatic Metastasis; Methotrexate; Mitomycin; Randomized Controlled Trials as Topic; Tamoxifen; Tegafur; Uracil | 1997 |
Current Clinical Trials in Non-muscle Invasive Bladder Cancer.
Topics: Adjuvants, Immunologic; Administration, Intravesical; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Immunological; Aziridines; BCG Vaccine; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Clinical Trials as Topic; Combined Modality Therapy; Humans; Indolequinones; Injections, Intradermal; Mitomycin; Muscle, Smooth; Neoplasm Invasiveness; Polysaccharides, Bacterial; Proteins; Recombinant Fusion Proteins; Tamoxifen; Typhoid-Paratyphoid Vaccines; Urinary Bladder Neoplasms; Urologic Surgical Procedures | 2018 |
A Systematic Review and Meta-analysis of Adjuncts to Minimally Invasive Treatment of Urethral Stricture in Men.
Topics: Captopril; Humans; Injections, Intralesional; Male; Mitomycin; Recurrence; Tamoxifen; Triamcinolone; Urethra; Urethral Stricture | 2021 |
17 trial(s) available for mitomycin and tamoxifen
Article | Year |
---|---|
Randomized adjuvant trial to evaluate the addition of tamoxifen and PSK to chemotherapy in patients with primary breast cancer. 5-Year results from the Nishi-Nippon Group of the Adjuvant Chemoendocrine Therapy for Breast Cancer Organization.
Topics: Adjuvants, Immunologic; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Middle Aged; Mitomycin; Proteoglycans; Survival Analysis; Tamoxifen; Tegafur | 1992 |
[Chemoendocrine therapy of gastric "scirrhous" carcinoma].
Topics: Adenocarcinoma, Scirrhous; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Mitomycin; Mitomycins; Stomach Neoplasms; Tamoxifen; Tegafur | 1988 |
A randomized trial of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer stratified by estrogen receptors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Humans; Mastectomy; Menopause; Mitomycin; Mitomycins; Ovariectomy; Receptors, Estrogen; Tamoxifen; Time Factors | 1988 |
[Cooperative research on post-operative adjuvant therapy of breast cancer. Tohoku Society of Adjuvant Chemo-endocrine Therapy of Breast Cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Mitomycin; Mitomycins; Postoperative Care; Random Allocation; Tamoxifen; Tegafur | 1988 |
[Metastatic breast cancer: controlled trial of chemotherapy with and without hormones].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Norethindrone; Tamoxifen; Teniposide; Vincristine | 1984 |
[Sex hormone dependency and endocrine therapy in diffuse carcinoma of the stomach].
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Male; Mice; Mice, Nude; Middle Aged; Mitomycin; Mitomycins; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Receptors, Estrogen; Stomach Neoplasms; Tamoxifen; Tegafur | 1983 |
[Present status of endocrine therapy of breast cancer: a surgeon's view].
Topics: Adrenalectomy; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Castration; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Hypophysectomy; Mitomycin; Mitomycins; Receptors, Estrogen; Tamoxifen | 1984 |
A pilot study of mitomycin-C and tamoxifen (MT) versus dibromodulcitol, adriamycin, and tamoxifen (DAT).
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Doxorubicin; Drug Therapy, Combination; Female; Humans; Mitolactol; Mitomycin; Mitomycins; Pilot Projects; Random Allocation; Soft Tissue Neoplasms; Tamoxifen | 1982 |
A cooperative randomized controlled study of adjuvant chemoendocrine therapy for breast cancer in Japan.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Lymphatic Metastasis; Mastectomy, Radical; Middle Aged; Mitomycin; Neoplasm Staging; Postmenopause; Postoperative Care; Survival Rate; Tamoxifen; Tegafur | 1994 |
[A comparative study among ftorafur, ftorafur plus tamoxifen, and tamoxifen in adjuvant therapy for breast cancer. The Chubu Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Cancer, Japan].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Female; Humans; Japan; Middle Aged; Mitomycin; Receptors, Estrogen; Survival Rate; Tamoxifen; Tegafur | 1993 |
A toxic interaction between mitomycin C and tamoxifen causing the haemolytic uraemic syndrome.
Topics: Adult; Aged; Anemia; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Drug Interactions; Female; Hemolytic-Uremic Syndrome; Humans; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Retrospective Studies; Tamoxifen; Thrombocytopenia | 1993 |
Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Female; Humans; Mammography; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Tamoxifen | 1996 |
Postoperative adjuvant randomised trial comparing chemoendocrine therapy, chemotherapy and immunotherapy for patients with stage II breast cancer: 5-year results from the Nishinihon Cooperative Study Group of Adjuvant Chemoendocrine Therapy for Breast Can
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunologic Factors; Middle Aged; Mitomycin; Neoplasm Metastasis; Proteoglycans; Survival Rate; Tamoxifen; Tegafur | 1996 |
Direct comparisons of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer patients stratified by estrogen receptor and menopausal status.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Estrogen Antagonists; Female; Humans; Menopause; Middle Aged; Mitomycin; Prospective Studies; Receptors, Estrogen; Tamoxifen | 1998 |
Prediction of response to neoadjuvant chemoendocrine therapy in primary breast carcinomas.
Topics: Adult; Age Factors; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Disease Progression; Female; Humans; Menopause; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging; Ploidies; Predictive Value of Tests; Proto-Oncogene Proteins c-bcl-2; Receptors, Estrogen; Receptors, Progesterone; S Phase; Tamoxifen | 1997 |
[A randomized study of adjuvant treatments for operable breast cancer patients stratified by estrogen receptor and menopausal status].
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Female; Humans; Mastectomy; Menopause; Middle Aged; Mitomycin; Receptors, Estrogen; Survival Rate; Tamoxifen | 1999 |
Tamoxifen combined with octreotide or regular chemotherapeutic agents in treatment of primary liver cancer: a randomized controlled trial.
Topics: Adult; Aged; alpha-Fetoproteins; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Female; Fluorouracil; Humans; Liver; Liver Function Tests; Liver Neoplasms; Male; Middle Aged; Mitomycin; Octreotide; Tamoxifen | 2003 |
35 other study(ies) available for mitomycin and tamoxifen
Article | Year |
---|---|
Structure-activity relationships of antineoplastic agents in multidrug resistance.
Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured | 1990 |
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
Topics: Adenosine Triphosphatases; Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding, Competitive; Calcium Channel Blockers; Cyclosporine; Detergents; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flow Cytometry; Fluoresceins; Humans; Ivermectin; Mice; NIH 3T3 Cells; Substrate Specificity | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Synthesis and docking studies of novel antitumor benzimidazoles.
Topics: Antineoplastic Agents; Benzimidazoles; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Herpesvirus 4, Human; Humans; Lung Neoplasms; MCF-7 Cells; Models, Molecular; Pyrroles; Structure-Activity Relationship; Tetracyclines; Virus Activation | 2012 |
Diversity-oriented synthesis of α-aminophosphonates: a new class of potential anticancer agents.
Topics: Antineoplastic Agents; Cell Line, Tumor; Chemistry Techniques, Synthetic; Humans; Organophosphonates; Permeability | 2013 |
[A case of complete response of locally advanced breast cancer to arterial infusion chemotherapy: cannulation through the right femoral artery and combined use of G-CSF].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Catheters, Indwelling; Cyclophosphamide; Doxorubicin; Female; Femoral Artery; Fluorouracil; Granulocyte Colony-Stimulating Factor; Humans; Infusions, Intra-Arterial; Infusions, Intravenous; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Tamoxifen | 1992 |
Evaluation of prognostic factors for 233 patients with recurrent advanced breast cancer.
Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Doxorubicin; Female; Humans; Liver Neoplasms; Methotrexate; Middle Aged; Mitomycin; Prognosis; Tamoxifen; Tegafur; Vincristine | 1991 |
[UFT-MT therapy in advanced or recurrent breast cancer].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Middle Aged; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Remission Induction; Tamoxifen; Tegafur; Uracil | 1990 |
Therapeutic strategies in inflammatory breast carcinoma based on prognostic factors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; France; Humans; Life Tables; Methotrexate; Mitomycin; Mitomycins; Multivariate Analysis; Radiotherapy Dosage; Remission Induction; Survival Rate; Tamoxifen; Vinblastine; Vincristine | 1990 |
[Analysis of prognostic factors in patients with locally advanced breast cancer treated with intra-arterial infusion chemotherapy as an induction therapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Female; Humans; Infusions, Intra-Arterial; Middle Aged; Mitomycin; Mitomycins; Preoperative Care; Prognosis; Remission Induction; Retrospective Studies; Tamoxifen; Tegafur | 1989 |
Primary medical therapy for operable breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Fluorouracil; Gonadotropin-Releasing Hormone; Hormones; Humans; Leuprolide; Methotrexate; Middle Aged; Mitomycin; Mitomycins; Mitoxantrone; Tamoxifen | 1989 |
[An analysis of treatments of recurrent breast cancer in relation to the lesion].
Topics: Breast Neoplasms; Combined Modality Therapy; Doxorubicin; Female; Humans; Lymphatic Metastasis; Medroxyprogesterone; Medroxyprogesterone Acetate; Mitomycin; Mitomycins; Neoplasm Recurrence, Local; Prognosis; Receptors, Estrogen; Tamoxifen | 1985 |
[Bone metastasis in advanced breast cancer].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Calcitonin; Cyclophosphamide; Doxorubicin; Female; Humans; Hypercalcemia; Methotrexate; Mitomycin; Mitomycins; Plicamycin; Tamoxifen; Tegafur | 1987 |
[Chemo-endocrine therapy of diffuse carcinoma of the stomach and its clinical evaluation].
Topics: Adenocarcinoma, Scirrhous; Adult; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Female; Gastrectomy; Humans; Male; Middle Aged; Mitomycin; Mitomycins; Receptors, Estrogen; Stomach Neoplasms; Tamoxifen; Tegafur | 1985 |
[Experimental chemo- and chemoendocrine therapy of human breast carcinomas serially transplanted into nude mice].
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Cyclophosphamide; Doxorubicin; Female; Fluorouracil; Humans; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Neoplasms, Hormone-Dependent; Tamoxifen | 1988 |
[Combined therapy of gastric cancer].
Topics: Antibiotics, Antineoplastic; Combined Modality Therapy; Emulsions; Gastrectomy; Humans; Hyperthermia, Induced; Mitomycin; Mitomycins; Stomach Neoplasms; Tamoxifen | 1985 |
[Sex hormone dependency in diffuse carcinoma of the stomach and results of chemo-endocrine therapy].
Topics: Adenocarcinoma, Scirrhous; Aged; Animals; Female; Gonadal Steroid Hormones; Humans; Male; Mice; Mice, Nude; Middle Aged; Mitomycin; Mitomycins; Neoplasms, Hormone-Dependent; Receptors, Androgen; Receptors, Estrogen; Receptors, Progesterone; Stomach Neoplasms; Tamoxifen; Tegafur | 1984 |
Combined cytotoxic and endocrine therapy for human breast carcinoma (Br-10) serially transplanted into nude mice.
Topics: Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Female; Humans; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Thymidine | 1984 |
[Experimental chemo- and endocrine-therapy of a human breast carcinoma cell line (MCF-7) in vitro and in vivo].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Division; Cell Line; Cyclophosphamide; Doxorubicin; Female; Humans; In Vitro Techniques; Mice; Mice, Nude; Mitomycin; Mitomycins; Neoplasm Transplantation; Tamoxifen | 1984 |
[Chemo- and endocrino-therapy of breast carcinoma xenografts in the dormant or exponential growth phase].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Cycle; Drug Screening Assays, Antitumor; Female; Mice; Mice, Inbred BALB C; Mice, Nude; Mitomycin; Neoplasm Transplantation; Tamoxifen | 1995 |
Use of erythropoietin in the management of the haemolytic uraemic syndrome induced by mitomycin C/tamoxifen.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Erythropoietin; Female; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Mitomycin; Tamoxifen | 1994 |
Semiautomated 14C-thymidine incorporation assay for in vitro screening of anticancer drug.
Topics: Adenocarcinoma; Antineoplastic Agents; Carbon Radioisotopes; Carcinoma, Signet Ring Cell; Cell Division; Drug Screening Assays, Antitumor; Fluorouracil; Humans; Mitomycin; Stomach Neoplasms; Tamoxifen; Thymidine; Tumor Cells, Cultured | 1993 |
Mammography in the assessment of response to medical treatment of large primary breast cancer.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Calcinosis; Cyclophosphamide; Female; Fluorouracil; Humans; Mammography; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Tamoxifen | 1993 |
[A case resectable hepatic metastases of breast cancer following intrahepatic arterial chemotherapy].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Female; Floxuridine; Hepatic Artery; Humans; Infusion Pumps, Implantable; Infusions, Intra-Arterial; Liver Neoplasms; Lymphatic Metastasis; Middle Aged; Mitomycin; Survival Rate; Tamoxifen | 1996 |
Haemolytic uraemic syndrome in a patient with lung cancer: further evidence for a toxic interaction between mitomycin-C and tamoxifen.
Topics: Antineoplastic Combined Chemotherapy Protocols; Female; Hemolytic-Uremic Syndrome; Humans; Lung Neoplasms; Middle Aged; Mitomycin; Tamoxifen | 1996 |
[Complete tumor regression obtained by chemoendocrine therapy including toremifene in two cases of pulmonary metastasis of breast cancer with a history of tamoxifen treatment].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cyclophosphamide; Female; Floxuridine; Humans; Lung Neoplasms; Middle Aged; Mitomycin; Remission Induction; Tamoxifen; Toremifene | 1997 |
Prognostic impact of second cancer on the survival of early breast cancer patients.
Topics: Adult; Androstanols; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Humans; Incidence; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Ovariectomy; Prognosis; Survival Analysis; Tamoxifen | 1999 |
Secondary myelodysplastic syndrome/acute myeloid leukaemia following mitoxantrone-based therapy for breast carcinoma.
Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; England; Female; Follow-Up Studies; Genetic Predisposition to Disease; Humans; Incidence; Leukemia, Myeloid; Leukemia, Radiation-Induced; Life Tables; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Myelodysplastic Syndromes; Neoplasms, Second Primary; Prospective Studies; Registries; Risk; Survival Analysis; Tamoxifen; Translocation, Genetic | 2000 |
[Hemolytic uremic syndrome--a serious complication of mitomycin treatment].
Topics: Adult; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Drug Interactions; Female; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Mitomycin; Tamoxifen | 1997 |
Intratumoral pyrimidine nucleoside phosphorylase (PyNPase) activity predicts a selective effect of adjuvant 5'-deoxy-5-fluorouridine (5'DFUR) on breast cancer.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Breast Neoplasms; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Chromatography, High Pressure Liquid; Disease-Free Survival; Female; Floxuridine; Fluorouracil; Follow-Up Studies; Humans; Lymphatic Metastasis; Mastectomy, Radical; Menopause; Middle Aged; Mitomycin; Neoplasm Proteins; Pentosyltransferases; Prodrugs; Pyrimidine Phosphorylases; Tamoxifen; Thymidine Phosphorylase; Treatment Outcome | 2000 |
Increased formation of micronuclei after hormonal stimulation of cell proliferation in human breast cancer cells.
Topics: Breast Neoplasms; Cell Cycle; Cell Division; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens; Hormones; Humans; Micronucleus Tests; Mitomycin; Receptors, Estrogen; Tamoxifen; Tumor Cells, Cultured | 2001 |
Patterns of care study of breast-conserving therapy in Japan: comparison of the treatment process between 1995 1997 and 1999 2001 surveys.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Doxorubicin; Female; Humans; Japan; Lymphatic Metastasis; Mastectomy, Segmental; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Neoplasm Staging; Paclitaxel; Population Surveillance; Practice Patterns, Physicians'; Radiotherapy, Adjuvant; Tamoxifen; Vinblastine; Vincristine | 2007 |
Tamoxifen reverses the multi-drug-resistance of an established human cholangiocarcinoma cell line in combined chemotherapeutics.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Cycle; Cell Line, Tumor; Cholangiocarcinoma; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Inhibitory Concentration 50; Intracellular Space; Mitomycin; RNA, Messenger; Tamoxifen; Vindesine | 2011 |